ChatGPT passes the nutrition test, but experts remain irreplaceable

ChatGPT offers accurate nutritional advice aligned with international guidelines for managing non-communicable diseases, yet struggles with complex patient scenarios.

Perspective’s early data on lead-based radiopharma asset suggest lower dose did better

In early-stage trials called dose escalation studies, drug developers usually want to test progressively higher doses of their therapies. Not Perspective Therapeutics. The radiopharma biotech

October 12, 2024

Cost Hurdles Can Keep Patients From Accessing GLP-1 Receptor Agonists

ANAHEIM, Calif. — Insurance coverage and out-of-pocket costs for GLP-1 receptor agonists pose serious barriers to patients prescribed these drugs for type 2 diabetes and

December 6, 2023

What a review of gender-affirming care research by a top pediatrics group actually means

When the American Academy of Pediatrics reaffirmed its support for gender-affirming care earlier this month, and called for a systematic review of the evidence, some

August 25, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.